ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
30 Outubro 2023 - 7:50AM
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today
announced that Nikhil Lalwani, Chief Executive Officer, and Stephen
Carey, Chief Financial Officer, will participate at two upcoming
healthcare conferences as follows:
Truist Securities BioPharma Symposium (1x1s
Only)
Date: |
|
Thursday,
November 9, 2023 |
To schedule a 1x1 meeting with management, please contact
Angela.Mouta@truist.com.
Jefferies London Healthcare Conference
Date: |
|
Wednesday,
November 15, 2023 |
|
|
|
Time: |
|
10:00am ET / 3:00pm GMT |
|
|
|
Webcast: |
|
Click here |
To schedule a 1x1 meeting with the Company, for November 14 or
November 15, please contact Isabel Zakoscielny
IZakoscielny@Jefferies.com.
The live and archived webcast will be accessible from the
Company’s website at www.anipharmaceuticals.com, under the
Investors section under Events and Presentations. The replay of the
webcast will be accessible for 90 days.
About ANI
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified
biopharmaceutical company serving patients in need by developing,
manufacturing, and marketing high quality branded and generic
prescription pharmaceutical products, including for diseases with
high unmet medical need. Our team is focused on delivering
sustainable growth by scaling up our Rare Disease business through
the successful launch of our lead asset, Purified Cortrophin® Gel,
strengthening our generics business with enhanced development
capability, innovation in established brands and leveraging our
North American manufacturing capabilities. For more information,
please visit our website www.anipharmaceuticals.com.
Investor Relations: Lisa M. Wilson, In-Site
Communications, Inc.T: 212-452-2793 E: lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals (NASDAQ:ANIP)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
ANI Pharmaceuticals (NASDAQ:ANIP)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024